Otsuka’s kidney therapy gets accelerated FDA approval
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and Drug Administration...
FDA
Saving lives with pig livers: FDA approves new trial with a spin on an old treatment
Another promising medical trial that could save lives thanks to genetically modified pigs: The FDA has given a select group...
FDA Approves SIR-Spheres for Liver Cancer Treatment
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both...
FDA clears Sora Neuroscience’s brain mapping software
Sora Neuroscience, a brain AI software company, announced it received FDA clearance for its Cirrus brain mapping software, which is...
Metastatic Liver Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND
DelveInsight’s, “Metastatic Liver Cancer Pipeline Insight” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Metastatic-Liver-Cancer pipeline...
HLB Reapply for Liver Cancer Drug Approval from FDA
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
